Competitive Intelligence

2024 CI EUROPE 650X650
Pharma CI Europe 2024
Pharma CI Europe 2024 650 650 Adarsh Hegde

Send your query Case Studies: 'Intellia' – A Digitalized Web-based CI Solution‘Intellia’ – A Digitalized Web-based CI Solution Clinical & Regulatory Timelines MonitoringClinical & Regulatory Timelines Monitoring Continuous CI Monitoring for Multiple IndicationsContinuous CI Monitoring for Multiple Indications Social Media Monitoring of BiosimilarsSocial Media Monitoring of Biosimilars Market AssessmentMarket Assessment Digitalized Platform Enabling Automated Work…

read more
2024 CI EUROPE 650X650
Pharma CI 2024 Download
Pharma CI 2024 Download 650 650 deepak

Welcome to DataZymes! We are a niche Data Analytics and AI solutions company focused on the pharmaceutical & biotech industries. We bring in a unique blend of Domain, Data & Technology expertise that enables us to build scalable and optimized analytics solutions. We thank you for your interest in downloading our brochure.

read more
Specialty Pharma
Specialty products in the pharma industry
Specialty products in the pharma industry 1024 506 deepak

In the recent years, there has been a lot of investment into research and development of Specialty products in the pharma industry, Specialty Drugs are highly specific, generally more effective, but significantly costlier to produce. However, though they are small volume, they are very high profit segment for Pharma companies. Hence, specialty Drugs play a…

read more
MicrosoftTeams Image 6
Reuters Pharma Conference 2024
Reuters Pharma Conference 2024 1024 373 deepak

Accelerate patient value. Pioneer healthcare’s transformation.   Healthcare reforms are finally paving the way to affordable access to medicines, yet this progress threatens the development of future life-saving therapies. The moment is now to prove ourselves as a trusted industry ally and the ultimate safe harbor for patients.  The key? Delivering aligned value to HCPs, patients, payers and…

read more
HCP Centric Approach
Is spending on consumer channels an effective marketing method or should pharma companies continue with an HCP centric approach?
Is spending on consumer channels an effective marketing method or should pharma companies continue with an HCP centric approach? 1024 683 deepak

Traditional Marketing Engagement in Pharma: A Background Excellent customer experiences are a key driver of business value in life sciences companies. However, pharma companies are yet to take advantage of this trend. Most struggle to offer a consistent level of engagement across digital and non-digital channels and face an uphill challenge for relevance. Marketing methods…

read more
Sentiment_analysis
Importance of Sentiment Mapping through Social Media Analysis: The Right Approach to CI Conferences
Importance of Sentiment Mapping through Social Media Analysis: The Right Approach to CI Conferences 1024 555 deepak

Introduction: Understanding Pharma CI Conferences Medical and scientific conferences are intersection points for industry dialogue and pharma company announcements. The interaction with KOLs makes such events important sources of primary and secondary competitive intelligence. Pharma companies participate in conference coverage by attending symposiums, oral, poster and booth sessions that gauge competitor positioning and messaging. They…

read more
Pharma CI Webniar E1640182330961
Pharma CI Conference
Pharma CI Conference 771 434 deepak

Send your query Case Studies: 'Intellia' – A Digitalized Web-based CI Solution‘Intellia’ – A Digitalized Web-based CI Solution Clinical & Regulatory Timelines MonitoringClinical & Regulatory Timelines Monitoring Continuous CI Monitoring for Multiple IndicationsContinuous CI Monitoring for Multiple Indications Social Media Monitoring of BiosimilarsSocial Media Monitoring of Biosimilars Market AssessmentMarket Assessment Digitalized Platform Enabling Automated Work…

read more
SI_Blog
Monitoring Development Milestones of Competitors in Pharma: A Brief Study
Monitoring Development Milestones of Competitors in Pharma: A Brief Study 1024 406 deepak

Competitor Monitoring in Pharma: Background The pharmaceutical organizations are facing a double whammy since the need for rapid innovation has been fuelled by evolving treatment landscapes and patient needs, and patent expiry for approved drugs. The need to keep the pipeline rich and strong has driven fierce competition in the industry. This in turn requires…

read more
Impact Of New Technologies In Pharma
Understanding the Impact of New Technologies in Pharma CI Data Journeys: Reversing Traditional Challenges
Understanding the Impact of New Technologies in Pharma CI Data Journeys: Reversing Traditional Challenges 1024 680 deepak

Background: Traditional Data Journeys in Pharma CI Drug companies are constantly driven by the need to innovate, discover drugs, and market them seamlessly globally. With average drug life cycles spanning two decades, right from the drug development, approval and commercialization, commercial competitive intelligence (CI) poses unique challenges. Traditional CI research includes practices such as wargaming,…

read more
Pharma CI Team Structures Impacts
How Pharma CI Team Structures impacts the Choice of CI Platforms?
How Pharma CI Team Structures impacts the Choice of CI Platforms? 1024 683 deepak

Background to CI Platforms and Team Structure in Pharma Historically, strategy teams must deal with unfathomable amount of data and it’s not just a competitive intelligence (CI) platform that does the trick in processing the data for insights. The structure of CI teams is also very crucial here in the way data is managed. The…

read more
Contact us